查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2012941

脑监测设备市场：按产品类型、技术、应用和最终用户划分 - 2026-2032年全球市场预测

Brain Monitoring Devices Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，脑监测设备市场价值将达到 30.2 亿美元，到 2026 年将成长至 32.2 亿美元，到 2032 年将达到 51.5 亿美元，复合年增长率为 7.91%。

主要市场统计数据
基准年 2025 30.2亿美元
预计年份：2026年 32.2亿美元
预测年份 2032 51.5亿美元
复合年增长率 (%) 7.91%

对正在重塑临床和研究环境中脑监测的技术、临床和护理服务趋势进行了简洁且具有前瞻性的概述。

随着感测技术、计算分析和医疗服务模式的整合发展，脑监测设备领域正在迅速演变，重新定义了神经系统评估和持续监测。临床医生正在寻求能够提供更高诊断准确性并适应日益分散的医疗服务路径的工具。同时，研究人员和设备开发人员也在积极探索各种方法，以减少就医障碍，提高患者舒适度，并将监测范围从一次性咨询扩展到收集长期真实世界数据。

详细说明了技术创新、分析突破和医疗保健服务变革的融合如何改变脑监测的功能和广泛应用。

近年来，一系列变革性的变化重新定义了脑监测设备的功能和应用场景。其中一个主要转变是从大型固定式设备向携带式可穿戴平台的过渡，这些平台能够在传统临床环境之外进行连续或移动监测。同时，结合脑电图、光学成像、磁振造影和代谢成像的多模态方法也迅速普及，这些方法能够提供关于脑部功能的互补观点。

对 2025 年美国关税变化将如何影响各设备类别的采购趋势、供应链和製造商策略进行策略评估。

美国2025年实施的关税调整对脑监测设备的整个价值链产生了复杂的连锁反应。关键零件和完整成像系统的进口关税增加了医疗机构和研究机构的采购成本，迫使采购负责人重新评估供应商选择标准和整体拥有成本（TCO）。因此，一些买家推迟了资本财的采购，或优先选择具有本地生产能力的供应商，以降低关税风险。

透过对细分市场、技术、应用、最终用户和产品类型的全面洞察，指导有针对性的产品开发和商业化策略。

深入了解市场区隔对于推动整个脑监测市场的产品开发、商业化和临床部署策略至关重要。从技术角度来看，该市场涵盖电脑断层扫描 (CT)、脑电图 (EEG)、功能性近红外线光谱 (fNIRS)、磁振造影(MRI)、脑磁图 (MEG) 和正子断层扫描 (PET)，每种技术都具有其独特的技术特性和临床效用。电脑断层扫描 (CT) 又可进一步分为锥状射束CT、常规 CT 和频谱CT，它们在空间解析度、辐射计量特性和应用领域方面存在差异。脑电图 (EEG) 包括携带式EEG、连续 EEG 监测、常规 EEG 和睡眠 EEG。携带式EEG 又可分为非穿戴式和可穿戴式，其中可穿戴式装置又可细分为帽式（注重全面覆盖）和头带式（注重用户便利性）。功能性近红外线光谱技术分为连续波、频域和时域技术，其中频域技术根据多距离和单距离配置进行区分，这会影响深度灵敏度和定量分析。磁振造影（MRI）包括常规MRI、高场MRI和低场MRI，高场系统又分为标准高场平台和超高场平台，后者可提供更高的对比和解析度。磁性电脑电图（MEG）分为基于光激励磁力计（OPM）的系统和基于超导量子干涉装置（SQUID）的系统，OPM平台又分为连续OPM和零场OPM。正子断层扫描（PET）产品线包括PET/CT一体机、PET/MRI混合系统和独立PET系统，每种系统都针对不同的诊断流程进行了最佳化。

区域洞察：医疗保健基础设施、管理体制和製造地的差异如何影响世界各地的部署模式。

由于医疗基础设施、法规环境以及研发生态系统的差异，区域趋势呈现明显的模式。在美洲，强大的临床研究基础和对先进诊断及监测能力的旺盛需求显而易见，重点在于能够融入医院工作流程并支持门诊服务扩展的解决方案。报销机制和临床医生对先进影像技术的熟练程度会影响技术的采用率，而在地化生产也在探索之中，以缓解关税带来的成本压力。

对大脑监测生态系统中定义领导地位和差异化的竞争定位、伙伴关係模式和策略措施进行详细分析。

脑监测设备生态系统的竞争动态由成熟的影像和诊断设备製造商、专注于神经技术的Start-Ups、软体分析供应商和组件供应商共同塑造。老字型大小企业通常凭藉广泛的系统产品组合、完善的服务网络和深入的临床检验展开竞争，而专业供应商则专注于特定领域的性能优势、创新外形规格或针对特定临床工作流程的软体差异化。Start-Ups往往在穿戴式脑电图 (EEG)、可携式脑磁图 (MEG) 和非侵入式光学感测等领域推动产品快速改进，而以软体为先的公司则优先考虑分析功能、云端连接和互通性，以探索新的应用情境。

为高阶主管提供有针对性、可操作的建议，以加强供应链韧性，加速软体主导的差异化，并将循证策略与商业性目标一致。

产业领导者应采取平衡策略，使产品创新与实际的商业性和营运需求相契合。首先，供应链多元化并考虑关键零件的近岸外包，可以降低关税波动风险，提高应对力。製造商应优先考虑模组化产品架构，以便于零件替换和快速配置变更，从而满足不同的临床和区域需求。这种设计柔软性可以缩短产品上市时间，并减轻供应中断的影响。

我们透明的调查方法结合了与主要相关人员的访谈、技术检验和情境分析，为相关人员提供可操作的、基于证据的见解。

本分析的调查方法结合了与领域专家的直接对话、严谨的技术审查和全面的二次检验，从而确保了分析结果的可靠性和可操作性。关键资料来源包括与临床医生、生物医学工程师、采购负责人和医疗设备开发人员的结构化访谈，旨在收集关于临床效用、采购标准和技术推广障碍的第一手观点。这些对话加深了我们对实际工作流程和未解决的需求的理解，而这些需求和需求又会影响医疗设备的需求和证据优先顺序。

明确且具有策略意义的结论，强调技术潜力、营运韧性和主导商业化之间的交集，以实现长期影响。

总之，脑监测设备市场正经历一场关键性的变革，其驱动力包括技术小型化、先进分析以及向分散式医疗模式的转变。这些因素为携带式、可穿戴式和多模态解决方案创造了新的机会，使监测范围能够从医院扩展到门诊和居家照护环境。同时，政策变化和价格调整也给供应链和采购带来了压力，迫使製造商和买家重新评估其采购方式、产品架构和定价策略。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 脑监测设备市场：依产品类型划分

  • 配件
    • 帽子
    • 电极
    • 感应器
  • 软体
    • 分析软体
    • 资料管理软体
  • 系统
    • 可携式系统
    • 静止系统

第九章：脑监测设备市场：依技术划分

  • CT
    • 锥状射束CT
    • 常规CT
    • 频谱CT
  • 脑电图（EEG）
    • 携带式脑电图
      • 不可穿戴
      • 穿戴式装置
      • 帽型
      • 头带类型
    • 连续脑电图监测
    • 常规脑电图
    • 睡眠脑电图
  • FNIRS
    • 连续波
    • 频域
      • 多距离
      • 单距离
    • 时域
  • 磁振造影
    • 常规磁振造影
    • 高场磁振造影
      • 标准高场
      • 超高磁场
    • 低场磁振造影
  • 脑磁图
    • OPM 基础
      • 环境 OPM
      • 零磁场 OPM
    • SQUID方法
  • PET
    • PET/CT
    • PET/MRI
    • 独立式PET

第十章：脑监测设备市场：依应用领域划分

  • 临床诊断
  • 居家照护
  • 研究

第十一章 脑监测设备市场：依最终用户划分

  • 诊断中心
  • 居家照护设施
  • 医院
  • 研究机构
    • 政府机构
    • 私营机构

第十二章 脑监测设备市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：脑监测设备市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章 脑监测设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国脑监测设备市场

第十六章：中国脑监测设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Brain Products GmbH
  • Cadwell Industries, Inc.
  • Cadwell Laboratories, Inc.
  • CAS Medical Systems, Inc.
  • Compumedics Limited
  • Dragerwerk AG & Co. KGaA
  • Elekta AB
  • EMOTIV Inc.
  • g.tec medical engineering GmbH
  • General Electric Company
  • Integra LifeSciences Corporation
  • Koninklijke Philips NV
  • Lifelines Neurodiagnostic Systems, Inc.
  • Medtronic plc
  • Mindray Medical International Limited
  • Natus Medical
  • Natus Medical Incorporated
  • Neural Analytics, Inc.
  • Neurosoft Ltd.
  • Nihon Kohden Corporation
  • Nonin Medical, Inc.
  • Rimed Inc.
  • Yokogawa Electric Corporation
Product Code: MRR-437D4595861A

The Brain Monitoring Devices Market was valued at USD 3.02 billion in 2025 and is projected to grow to USD 3.22 billion in 2026, with a CAGR of 7.91%, reaching USD 5.15 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.02 billion
Estimated Year [2026] USD 3.22 billion
Forecast Year [2032] USD 5.15 billion
CAGR (%) 7.91%

A concise and forward-looking introduction to the shifting technological, clinical, and care delivery forces reshaping brain monitoring across clinical and research settings

The landscape of brain monitoring devices is evolving rapidly as advances in sensing technology, computational analytics, and care delivery models converge to redefine neurological assessment and continuous monitoring. Clinicians are seeking tools that deliver higher diagnostic confidence while fitting into increasingly decentralized care pathways. At the same time, researchers and device developers are pushing for modalities that reduce barriers to access, improve patient comfort, and extend monitoring beyond episodic encounters into longitudinal, real-world data capture.

In parallel, improvements in signal processing, miniaturized sensors, and low-field imaging platforms are creating opportunities for new device form factors and use cases. These technological enablers are further amplified by the maturation of software-driven analytics, which transform raw physiological signals into actionable insights for diagnosis, treatment planning, and outcome tracking. As a result, stakeholders across healthcare, research, and home care contexts are reevaluating clinical workflows and procurement priorities to incorporate solutions that balance performance, usability, and cost-effectiveness.

Regulatory pathways and reimbursement environments are also adapting, prompting manufacturers and healthcare providers to align product development and evidence-generation strategies closely with clinical needs. Collectively, these dynamics are accelerating the transition from purely hospital-centric imaging and monitoring to hybrid models that integrate hospital, outpatient, and home-based monitoring, thereby expanding the role of brain monitoring devices in both acute and chronic care management.

An in-depth account of the converging technological innovations, analytics breakthroughs, and care delivery shifts that are transforming brain monitoring capabilities and adoption

Recent years have seen a series of transformative shifts that are redefining what brain monitoring devices can achieve and where they can be deployed. A primary shift is the transition from large, stationary instruments toward portable and wearable platforms that enable continuous or ambulatory monitoring outside traditional clinical environments. This movement is accompanied by a proliferation of multimodal approaches that combine electroencephalography with optical, magnetic, and metabolic imaging to provide complementary perspectives on brain function.

Another major transformation is the integration of advanced analytics, including machine learning and cloud-based pipelines, which convert complex physiological datasets into clinically relevant outputs. These analytics enable faster interpretation, pattern recognition across large cohorts, and predictive modeling that supports early intervention. Concurrently, hardware innovations-such as compact sensor arrays, low-field magnetic resonance imaging systems, and optically pumped magnetometers-are lowering the barriers to adoption by reducing cost, footprint, and operational complexity.

Ecosystem-level changes are also notable. The proliferation of home care and ambulatory applications is shifting centricity toward patient convenience and long-term monitoring, necessitating stronger emphasis on device comfort, data security, and remote device management. Supply chain diversification and onshoring initiatives are influencing manufacturing strategies, while evolving regulatory expectations demand robust clinical validation and post-market surveillance. Taken together, these shifts are not isolated; they compound each other to reshape product roadmaps, reimbursement strategies, and clinical workflows across acute care, outpatient settings, and research environments.

A strategic assessment of how the United States tariff changes in 2025 altered procurement dynamics, supply chains, and manufacturer strategies across device categories

The tariff adjustments introduced in the United States in 2025 have created a complex set of consequences that reverberate across the brain monitoring device value chain. Import levies on key components and finished imaging systems have increased procurement costs for healthcare providers and research institutions, prompting procurement officers to reassess vendor selection criteria and total cost of ownership. As a result, some buyers are delaying capital purchases or favoring suppliers with localized manufacturing footprints to mitigate tariff exposure.

These changes have ripple effects across product categories. High-capital systems, including advanced magnetic resonance platforms and integrated PET solutions, face particular sensitivity to component price inflation and logistics constraints. At the same time, the accessories and consumables ecosystem-caps, electrodes, sensors-has experienced tighter margin pressure, which challenges distributors and hospital supply managers to renegotiate contracts or seek alternative suppliers. For software-centric vendors, tariffs on computing hardware and peripheral devices affect deployment strategies, particularly for bundled offerings that include edge processing units or specialized servers.

Manufacturers are responding with strategic shifts that include nearshoring of production, diversification of supplier bases, and reengineering of product designs to reduce dependency on tariffed components. These strategic moves often require upfront capital and a recalibration of inventory and logistics practices. Procurement implications are amplified in settings where budgets are constrained, such as public hospitals and certain research institutes, which may prioritize cost containment over early adoption of the latest modalities. In sum, the 2025 tariff landscape has accelerated supply-side restructuring and introduced demand-side caution, reshaping procurement timelines and product strategies across the ecosystem.

Comprehensive segmentation insights that map technologies, applications, end users, and product types to guide targeted product development and commercialization strategies

A granular understanding of segmentation is essential to navigate product development, commercialization, and clinical adoption strategies across the brain monitoring landscape. From a technology perspective, the market encompasses computed tomography, electroencephalography, functional near-infrared spectroscopy, magnetic resonance imaging, magnetoencephalography, and positron emission tomography, each with distinct technical attributes and clinical utilities. Computed tomography is differentiated across cone beam CT, conventional CT, and spectral CT, which vary in spatial resolution, dose characteristics, and application focus. Electroencephalography spans ambulatory EEG, continuous EEG monitoring, routine EEG, and sleep EEG, with ambulatory modalities further bifurcating into non-wearable and wearable formats, and wearable devices subdivided into cap-based and headband-based designs that prioritize either comprehensive coverage or user convenience. Functional near-infrared spectroscopy is divided into continuous wave, frequency domain, and time domain technologies, with frequency domain approaches further differentiated by multi-distance and single-distance configurations that affect depth sensitivity and quantification. Magnetic resonance imaging includes conventional MRI, high field MRI, and low field MRI, where high field systems are further distinguished between standard high field and ultra high field platforms that drive advanced contrast and resolution. Magnetoencephalography is distinguished between optically pumped magnetometer-based systems and SQUID-based systems, with OPM platforms further categorized into ambient OPM and zero field OPM variants. Positron emission tomography offerings include integrated PET/CT, hybrid PET/MRI, and standalone PET systems, each optimized for different diagnostic workflows.

Analyzing applications reveals three primary use cases: clinical diagnostics, home care, and research. Clinical diagnostics prioritize robustness, regulatory clearance, and integration into established care pathways. Home care emphasizes ease of use, comfort, and remote data transmission capabilities to support longitudinal monitoring and chronic disease management. Research applications demand flexibility, raw data access, and modalities suited to experimental protocols.

End users cut across diagnostics centers, home care settings, hospitals, and research institutes, with research institutes subdivided into governmental and private entities that have differing procurement cycles and funding models. Diagnostics centers typically focus on throughput and cost-efficiency, hospitals on versatility and integration with electronic health records, home care settings on patient experience and remote monitoring infrastructure, and research institutes on customization and data fidelity.

Product types span accessories, software, and systems. Accessories encompass caps, electrodes, and sensors that directly influence signal quality and patient comfort. Software includes analysis software and data management software, which are core to translating physiological signals into clinical insights and enabling secure longitudinal data storage. Systems are categorized into portable systems and stationary systems, reflecting trade-offs between mobility and advanced imaging performance. Understanding these segmentation dimensions in tandem enables stakeholders to identify niches for innovation, prioritize evidence generation, and tailor commercial strategies to the specific demands of each buyer group.

Region-specific insights describing how differing healthcare infrastructure, regulatory regimes, and manufacturing footprints dictate adoption patterns across global territories

Regional dynamics exhibit distinct patterns driven by differences in healthcare infrastructure, regulatory environments, and R&D ecosystems. The Americas reflect a strong clinical research base and high demand for advanced diagnostic and monitoring capabilities, with emphasis on solutions that integrate into hospital workflows and support outpatient expansions. Reimbursement frameworks and clinician familiarity with advanced imaging modalities influence adoption velocity, and localized manufacturing initiatives are being explored to mitigate tariff-driven cost pressures.

Europe, Middle East & Africa present a heterogeneous landscape where regulatory harmonization in certain areas supports cross-border device approvals, yet varying healthcare budgets and infrastructure create distinct market niches. In parts of this region, public health programs and academic research centers drive demand for versatile systems and flexible acquisition models, while other markets prioritize cost-effective, portable solutions suitable for decentralized care delivery. Supply chain resilience and compliance with diverse regulatory regimes are key considerations for vendors operating across this broad region.

Asia-Pacific is characterized by rapid adoption of innovative device form factors and a robust manufacturing base that supports both original equipment production and component supply. Large urban centers with sizable patient volumes drive interest in high-throughput diagnostics, while emerging markets within the region prioritize low-cost, easy-to-deploy systems and remote monitoring technologies to address access gaps. Regional partnerships and local regulatory engagement are effective strategies for market entry and scale in this diverse landscape.

Taken together, regional strategies must balance global product standardization with local adaptations in pricing, evidence generation, and service models. Manufacturers that align product roadmaps with region-specific reimbursement, regulatory, and clinical practice realities are positioned to capture broader adoption across these distinct geographies.

A nuanced view of competitive positioning, partnership models, and strategic moves that define leadership and differentiation within the brain monitoring ecosystem

Competitive dynamics in the brain monitoring device ecosystem are shaped by a mix of established imaging and diagnostics firms, specialized neurotechnology startups, software analytics vendors, and component suppliers. Established firms typically compete on the basis of broad systems portfolios, service networks, and deep clinical validation, whereas specialist vendors focus on niche performance advantages, innovative form factors, or software-enabled differentiation that targets specific clinical workflows. Startups often drive rapid iteration in wearable EEG, portable MEG, and noninvasive optical sensing, while software-first companies emphasize analytics, cloud connectivity, and interoperability to unlock new use cases.

Collaboration is a defining feature of the landscape: partnerships between device manufacturers and analytics providers accelerate the translation of raw signals into decision-ready outputs, and alliances with research institutes enable rigorous validation studies that support clinical adoption. Similarly, component suppliers and contract manufacturers play a critical role in determining product cost structures and time-to-market, especially as firms respond to supply chain pressures and tariff-driven cost shifts.

Strategic corporate actions such as targeted acquisitions, licensing deals, and co-development agreements are common as companies seek to expand capabilities or enter adjacent clinical segments. Service and maintenance offerings, training programs, and managed services have emerged as important differentiators that enhance customer retention and lifetime value. Overall, the competitive environment rewards organizations that combine technical excellence with scalable commercialization models and strong clinical partnerships.

Targeted and actionable recommendations for executives to strengthen supply resilience, accelerate software-driven differentiation, and align evidence strategies with commercial goals

Industry leaders should pursue a balanced strategy that aligns product innovation with pragmatic commercial and operational imperatives. First, diversifying supply chains and evaluating nearshoring for critical components will reduce exposure to tariff volatility and improve responsiveness. Manufacturers should prioritize modular product architectures that allow substitution of components and facilitate rapid configuration for different clinical and regional requirements. This engineering flexibility will accelerate time-to-market and lower the impact of supply disruptions.

Second, investing in robust software and analytics capabilities is essential. Software not only enhances device value through improved interpretation and workflow integration, but also creates recurring revenue opportunities and strengthens customer lock-in. Leaders should build interoperable platforms that support standardized data formats, secure cloud connectivity, and clinician-centric interfaces to facilitate adoption across hospitals, diagnostics centers, and home care settings.

Third, evidence generation and regulatory strategy must be tightly coordinated. Prioritizing clinical studies that demonstrate real-world utility, cost-effectiveness, and patient-centered outcomes will streamline payer engagement and support reimbursement discussions. Engaging early with regulators and payers enables more predictable pathways for clearance and coverage. Additionally, companies should expand service offerings and training programs to ensure optimal clinical integration and to reduce the burden on end users.

Finally, strategic partnerships with research institutes, local distributors, and technology providers can accelerate market entry and scale. Joint initiatives that combine hardware, software, and clinical expertise will be particularly effective in demonstrating value in specialty areas such as continuous monitoring, neurocritical care, and home-based chronic disease management. By aligning operational resilience, software differentiation, clinical evidence, and collaborative go-to-market strategies, industry leaders can navigate current headwinds and capture growth opportunities across diverse care settings.

A transparent methodology combining primary stakeholder interviews, technical validation, and scenario analysis to produce actionable and evidence-based insights for stakeholders

The research methodology underpinning this analysis combines primary engagement with domain experts, rigorous technical review, and comprehensive secondary validation to ensure robust and actionable insights. Primary inputs include structured interviews with clinicians, biomedical engineers, procurement professionals, and device developers to capture firsthand perspectives on clinical utility, procurement criteria, and technology adoption barriers. These conversations inform an understanding of real-world workflows and unmet needs that shape device requirements and evidence priorities.

Secondary analysis synthesizes peer-reviewed literature, regulatory approvals and guidance documents, patent filings, and clinical trial registries to assess technology maturity and validate claims about performance and safety. Supply chain mapping and component-level assessment provide visibility into manufacturing dependencies, logistics pathways, and potential bottlenecks. Comparative technology assessments evaluate trade-offs among modalities in terms of sensitivity, specificity, usability, and integration complexity.

Scenario-based analysis explores the implications of policy shifts, tariff changes, and technological breakthroughs on adoption pathways and procurement decisions. Cross-validation across multiple data streams ensures that conclusions are corroborated and that recommendations remain grounded in practical constraints. Throughout, the methodology emphasizes transparency in assumptions and a focus on evidence that supports adoption, regulatory clearance, and integration into clinical practice.

A decisive and strategic conclusion emphasizing the intersection of technological promise, operational resilience, and evidence-driven commercialization for long-term impact

In conclusion, the brain monitoring device landscape is undergoing a pivotal transformation driven by technological miniaturization, advanced analytics, and a shift toward decentralized care models. These forces are creating new opportunities for portable, wearable, and multimodal solutions that can extend monitoring beyond hospitals into outpatient and home care settings. At the same time, policy changes and tariff adjustments are exerting pressure on supply chains and procurement, prompting manufacturers and buyers to rethink sourcing, product architecture, and pricing strategies.

The ability to succeed in this environment depends on aligning engineering flexibility with strong software capabilities and a disciplined evidence-generation strategy that speaks to clinicians, payers, and procurement authorities. Regional nuances matter: adoption pathways differ across the Americas, Europe, Middle East & Africa, and Asia-Pacific, and companies must tailor approaches to local regulatory, reimbursement, and infrastructure realities. By focusing on modularity, interoperability, clinical validation, and supply resilience, stakeholders can translate emerging technological promise into scalable clinical impact and sustainable commercial models.

Ultimately, the organizations that integrate technical innovation with pragmatic commercialization and strategic partnerships will be best positioned to deliver meaningful improvements in neurological care and to capture long-term opportunities across clinical and research domains.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Brain Monitoring Devices Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Caps
    • 8.1.2. Electrodes
    • 8.1.3. Sensors
  • 8.2. Software
    • 8.2.1. Analysis Software
    • 8.2.2. Data Management Software
  • 8.3. Systems
    • 8.3.1. Portable Systems
    • 8.3.2. Stationary Systems

9. Brain Monitoring Devices Market, by Technology

  • 9.1. CT
    • 9.1.1. Cone Beam CT
    • 9.1.2. Conventional CT
    • 9.1.3. Spectral CT
  • 9.2. Electroencephalography
    • 9.2.1. Ambulatory EEG
      • 9.2.1.1. Non Wearable
      • 9.2.1.2. Wearable
      • 9.2.1.2.1. Cap Based
      • 9.2.1.2.2. Headband Based
    • 9.2.2. Continuous EEG Monitoring
    • 9.2.3. Routine EEG
    • 9.2.4. Sleep EEG
  • 9.3. FNIRS
    • 9.3.1. Continuous Wave
    • 9.3.2. Frequency Domain
      • 9.3.2.1. Multi Distance
      • 9.3.2.2. Single Distance
    • 9.3.3. Time Domain
  • 9.4. Magnetic Resonance Imaging
    • 9.4.1. Conventional MRI
    • 9.4.2. High Field MRI
      • 9.4.2.1. Standard High Field
      • 9.4.2.2. Ultra High Field
    • 9.4.3. Low Field MRI
  • 9.5. Magnetoencephalography
    • 9.5.1. OPM Based
      • 9.5.1.1. Ambient OPM
      • 9.5.1.2. Zero Field OPM
    • 9.5.2. SQUID Based
  • 9.6. PET
    • 9.6.1. PET/CT
    • 9.6.2. PET/MRI
    • 9.6.3. Standalone PET

10. Brain Monitoring Devices Market, by Application

  • 10.1. Clinical Diagnostics
  • 10.2. Home Care
  • 10.3. Research

11. Brain Monitoring Devices Market, by End User

  • 11.1. Diagnostics Centers
  • 11.2. Home Care Settings
  • 11.3. Hospitals
  • 11.4. Research Institutes
    • 11.4.1. Government Institutes
    • 11.4.2. Private Institutes

12. Brain Monitoring Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Brain Monitoring Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Brain Monitoring Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Brain Monitoring Devices Market

16. China Brain Monitoring Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. B. Braun Melsungen AG
  • 17.6. Becton, Dickinson and Company
  • 17.7. Brain Products GmbH
  • 17.8. Cadwell Industries, Inc.
  • 17.9. Cadwell Laboratories, Inc.
  • 17.10. CAS Medical Systems, Inc.
  • 17.11. Compumedics Limited
  • 17.12. Dragerwerk AG & Co. KGaA
  • 17.13. Elekta AB
  • 17.14. EMOTIV Inc.
  • 17.15. g.tec medical engineering GmbH
  • 17.16. General Electric Company
  • 17.17. Integra LifeSciences Corporation
  • 17.18. Koninklijke Philips N.V.
  • 17.19. Lifelines Neurodiagnostic Systems, Inc.
  • 17.20. Medtronic plc
  • 17.21. Mindray Medical International Limited
  • 17.22. Natus Medical
  • 17.23. Natus Medical Incorporated
  • 17.24. Neural Analytics, Inc.
  • 17.25. Neurosoft Ltd.
  • 17.26. Nihon Kohden Corporation
  • 17.27. Nonin Medical, Inc.
  • 17.28. Rimed Inc.
  • 17.29. Yokogawa Electric Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BRAIN MONITORING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BRAIN MONITORING DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES BRAIN MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA BRAIN MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTRODES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTRODES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTRODES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SENSORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SENSORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SENSORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ANALYSIS SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ANALYSIS SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ANALYSIS SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DATA MANAGEMENT SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PORTABLE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STATIONARY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STATIONARY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STATIONARY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONE BEAM CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONE BEAM CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONE BEAM CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SPECTRAL CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SPECTRAL CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SPECTRAL CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY NON WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAP BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAP BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CAP BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HEADBAND BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HEADBAND BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HEADBAND BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS EEG MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS EEG MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS EEG MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ROUTINE EEG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ROUTINE EEG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ROUTINE EEG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SLEEP EEG, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SLEEP EEG, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SLEEP EEG, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONTINUOUS WAVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MULTI DISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MULTI DISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MULTI DISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SINGLE DISTANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SINGLE DISTANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SINGLE DISTANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TIME DOMAIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TIME DOMAIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY TIME DOMAIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CONVENTIONAL MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDARD HIGH FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDARD HIGH FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDARD HIGH FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ULTRA HIGH FIELD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ULTRA HIGH FIELD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ULTRA HIGH FIELD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY LOW FIELD MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY LOW FIELD MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY LOW FIELD MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBIENT OPM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBIENT OPM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY AMBIENT OPM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ZERO FIELD OPM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ZERO FIELD OPM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY ZERO FIELD OPM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SQUID BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SQUID BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY SQUID BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/CT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/CT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/CT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/MRI, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/MRI, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PET/MRI, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDALONE PET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDALONE PET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY STANDALONE PET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY DIAGNOSTICS CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY GOVERNMENT INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY GOVERNMENT INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRIVATE INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRIVATE INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY PRIVATE INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL BRAIN MONITORING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 191. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, 2018-2032 (USD MILLION)
  • TABLE 192. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, 2018-2032 (USD MILLION)
  • TABLE 193. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 194. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, 2018-2032 (USD MILLION)
  • TABLE 195. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 196. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, 2018-2032 (USD MILLION)
  • TABLE 197. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 198. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. AMERICAS BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 211. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, 2018-2032 (USD MILLION)
  • TABLE 212. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, 2018-2032 (USD MILLION)
  • TABLE 213. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 214. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, 2018-2032 (USD MILLION)
  • TABLE 215. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 216. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, 2018-2032 (USD MILLION)
  • TABLE 217. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 218. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 219. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. NORTH AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 229. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2018-2032 (USD MILLION)
  • TABLE 230. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 231. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, 2018-2032 (USD MILLION)
  • TABLE 232. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, 2018-2032 (USD MILLION)
  • TABLE 233. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 234. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, 2018-2032 (USD MILLION)
  • TABLE 235. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 236. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, 2018-2032 (USD MILLION)
  • TABLE 237. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 238. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 239. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 240. LATIN AMERICA BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPE, MIDDLE EAST & AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPE BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 281. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 282. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 284. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 285. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 286. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 288. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 289. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2018-2032 (USD MILLION)
  • TABLE 290. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 291. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS, 2018-2032 (USD MILLION)
  • TABLE 292. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY FREQUENCY DOMAIN, 2018-2032 (USD MILLION)
  • TABLE 293. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, 2018-2032 (USD MILLION)
  • TABLE 294. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY HIGH FIELD MRI, 2018-2032 (USD MILLION)
  • TABLE 295. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY MAGNETOENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 296. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY OPM BASED, 2018-2032 (USD MILLION)
  • TABLE 297. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY PET, 2018-2032 (USD MILLION)
  • TABLE 298. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 299. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. MIDDLE EAST BRAIN MONITORING DEVICES MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
  • TABLE 301. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 302. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 303. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 304. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 305. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 306. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 307. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY CT, 2018-2032 (USD MILLION)
  • TABLE 308. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY ELECTROENCEPHALOGRAPHY, 2018-2032 (USD MILLION)
  • TABLE 309. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY AMBULATORY EEG, 2018-2032 (USD MILLION)
  • TABLE 310. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY WEARABLE, 2018-2032 (USD MILLION)
  • TABLE 311. AFRICA BRAIN MONITORING DEVICES MARKET SIZE, BY FNIRS,